返回产品
威格顿生物 徐州威格顿生物科技有限公司
威格顿生物
威格顿生物 Weigedun Biotechnology
产品说明书

CLEC12A Mouse mAb

货号WGD-Z-2611663 更新日期2026-08-30
规格信息
规格货号
50ul WGD-Z-2611663
100ul WGD-Z-2611663
详细参数
别名 C-type lectin domain family 12 member A; C-type lectin-like molecule 1; CLL-1; Dendritic cell-associated lectin 2; DCAL-2; Killer cell C-type lectin-like receptor L1; hKLRL1; Myeloid inhibitory C-type lectin-like receptor; MICL; CD antigen CD371
基因名 CLEC12A
UniProt ID Q5QGZ9
反应种属 Human
应用 IHC-P
宿主 Mouse
偶联物 Unconjugated
修饰 Unmodified
亚型 IgG1
克隆号 7E3-H8-A5
克隆性 Monoclonal Antibody
分子量 Calculated MW: 30 kDa
纯化方式 Affinity Purified
产品形式 Liquid
推荐稀释比 IHC-1:1000
存储缓冲液 Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.09% sodium azide
保存温度 Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
背景信息 C-type lectin domain family 12 member A (CLEC12A), also known as MICL or CLL-1, is a type II transmembrane glycoprotein and an inhibitory member of the C-type lectin-like receptor superfamily. Predominantly expressed on myeloid cells, it functions as a pattern recognition receptor that binds diverse ligands, including monosodium urate (MSU) crystals and mycobacterial mycolic acid. Upon ligand engagement, CLEC12A undergoes Src-dependent phosphorylation of its cytoplasmic immunoreceptor tyrosine-based inhibitory motif (ITIM), recruiting phosphatases SHP-1 and SHP-2 to dampen pro-inflammatory signaling. This mechanism suppresses neutrophil activation and cytokine release while facilitating antigen cross-presentation and antibacterial autophagy. Clinically, the downregulation of CLEC12A exacerbates inflammatory conditions such as gouty arthritis. Additionally, CLEC12A is a well-established cell surface marker for leukemic blasts in acute myeloid leukemia (AML).